• Contact us
  • CSR
  • Insud Pharma
  • Español
mAbxience is a fully integrated biopharmaceutical company specialized in research, development and manufacturing of biosimilars for the treatment and/or prevention of several diseases in diverse therapeutic areas.
  •  Company
    • About mAbxience
    • CEO message
    • Leadership team
    • Business development and commercial team
    • Business growth story
    • Our philosophy
    • Our locations
  • R&D
    • Design philosophy
    • Portfolio
  • Manufacturing
    • Argentina: mAbxience Buenos Aires – Garín
    • Argentina: mAbxience Buenos Aires – Munro
    • Spain: mAbxience León
    • Fill & finish partners
  • Partnerships
    • Partnerships
    • CDMO
  • Media
    • News
    • What’s next? meet us at…
    • Blog mAbxience
  • Join us
  •  Company
    • About mAbxience
    • CEO message
    • Leadership team
    • Business development and commercial team
    • Business growth story
    • Our philosophy
    • Our locations
  • R&D
    • Design philosophy
    • Portfolio
  • Manufacturing
    • Argentina: mAbxience Buenos Aires – Garín
    • Argentina: mAbxience Buenos Aires – Munro
    • Spain: mAbxience León
    • Fill & finish partners
  • Partnerships
    • Partnerships
    • CDMO
  • Media
    • News
    • What’s next? meet us at…
    • Blog mAbxience
  • Join us
  • Contact us
  • CSR
  • Insud Pharma
  • Español
  • Contact us
  • CSR
  • Insud Pharma
  • Español
mAbxience is a fully integrated biopharmaceutical company specialized in research, development and manufacturing of biosimilars for the treatment and/or prevention of several diseases in diverse therapeutic areas.
  •  Company
    • About mAbxience
    • CEO message
    • Leadership team
    • Business development and commercial team
    • Business growth story
    • Our philosophy
    • Our locations
  • R&D
    • Design philosophy
    • Portfolio
  • Manufacturing
    • Argentina: mAbxience Buenos Aires – Garín
    • Argentina: mAbxience Buenos Aires – Munro
    • Spain: mAbxience León
    • Fill & finish partners
  • Partnerships
    • Partnerships
    • CDMO
  • Media
    • News
    • What’s next? meet us at…
    • Blog mAbxience
  • Join us
  •  Company
    • About mAbxience
    • CEO message
    • Leadership team
    • Business development and commercial team
    • Business growth story
    • Our philosophy
    • Our locations
  • R&D
    • Design philosophy
    • Portfolio
  • Manufacturing
    • Argentina: mAbxience Buenos Aires – Garín
    • Argentina: mAbxience Buenos Aires – Munro
    • Spain: mAbxience León
    • Fill & finish partners
  • Partnerships
    • Partnerships
    • CDMO
  • Media
    • News
    • What’s next? meet us at…
    • Blog mAbxience
  • Join us
  • Contact us
  • CSR
  • Insud Pharma
  • Español

mAbxience | Glossary

Find here all you need!

VIEW ALL
A - Z
Z - A
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

T

TRACEABILITY

S

SUBSTITUTION

SINGLE-USE TECHNOLOGY

SIMILARITY

R

Risk management system

Q

QUALITY

P

PHARMACOVIGILANCE

PHARMACOKINETIC TEST

PHARMACODYNAMIC TEST

PERFORMACE QUALIFICATION

Patent

O

OUTSOURCING ACTIVITIES

ORIGINATOR COMPANY

M

MONOCLONAL ANTIBODY (MAB)

MEDIA

MCB (MASTER CELL BANK)

Marketing authorisation

MANUFACTURING SCALE PRODUCTION

Mab

I

INTERCHANGEABILITY

INNOVATIVE REFERENCE DRUG

IMMUNOGENICITY

H

HLA

HIGH-AFFINITY ANTIBODY

HAPTEN

G

GMP

GLYCOSYLATION

GENETIC ENGINEERING

GENE TRANSFER

F

Fucosylation

FORMULATION

FINGERPRINT-LIKE

FEED

FDA

E

EXTRAPOLATION

EMA

C

COMPARABILITY

CLONE

CLINICAL STUDY TRIAL

CHMP

CHIMERIC TRANSGENE

cGMP

CELL LINE

CELL HARVESTING

CELL CULTURE

CELL BANK

CBER

B

BIOTECHNOLOGY

BIOSIMILARITY

BIOSIMILAR

BioSim

BIOPROCESSING

BIOPHARMACEUTICAL

BIOLOGICAL DRUGS

BIOEQUIVALENCE

BIOAVAILABILITY

BIOACTIVITY

BINDING

BATCH CULTURE

BACULOVIRUS

BACTERIOPHAGE

A

AVIDITY

ANTIGENITCITY

ANTIGEN DETERMINANT

ANTIGEN

ANTIBODY

Active ingredient (or active substance)

  • Portfolio
  • Blog mAbxience
  • Contact Us
  • Privacy & Terms
  • Cookies Policy
  • Glossary

© 2021 mAbxience, creating a strong value in biopharmaceuticals